Clinical Trial Update: A Study of Mesenchymal Stem Cell in the Treatment of Autism Spectrum Disorder [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating mesenchymal stem cells for autism spectrum disorder is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autism Spectrum Disorder

Drugs mentioned

• Mesenchymal Stem Cell (mesenchymal stem cell)

Snippet

Sponsor: Jiuzhitang Maker (Beijing) Cell Technology Co.,Ltd. | Conditions: Autism Spectrum Disorder | Phase 1 | Status: NOT_YET_RECRUITING